Control Medical Technology announced on May 7 that the FDA cleared the company’s Control 7 – 11F Mechanical Thrombectomy platform to remove blood clots from peripheral vessels. The device provides clinicians with a more cost-effective tool to remove blood clots. “This FDA clearance quadruples our product offering and improves our ability to help patients,” said […]
The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES) to coordinate SARS-CoV-2 sequencing across the U.S. Utah’s own IDbyDNA will be participating in the effort along with clinical and public health laboratories, academic institutions, and other private sector companies. The SPHERES consortium aims to generate information […]
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner of the State of Utah for many years. As a German investment promotion agency, we can observe the economic trends developing in our crisis-stricken global economy first-hand. We are honored that BioUtah has asked us to provide […]
BioUtah’s newest Associate Member is Greg Gunn at Colliers International. With over 35 years of experience in commercial real estate, Greg has negotiated over $700 million in leases representing properties anywhere from 1,000 to 145,000 square feet in size. As a Senior Vice President at Colliers International, Greg has been impressed with the growth of […]